Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Kaival Brands Innovations Group	KAVL	29. nov 2024	0.72	-1.42
Kaixin Holdings	KXIN	29. nov 2024	1.96	-1.01
Kala Bio	KALA	29. nov 2024	6.86	+3.12
Kaltura	KLTR	29. nov 2024	2.22	+2.78
KalVista Pharmaceuticals	KALV	29. nov 2024	10.06	-0.30
Kamada	KMDA	29. nov 2024	5.89	+1.38
Kandi Technologies Group	KNDI	29. nov 2024	1.23	-2.38
Kanzhun ADR	BZ	29. nov 2024	13.50	+7.31
Karat Packaging	KRT	29. nov 2024	30.89	+1.41
Karooooo	KARO	29. nov 2024	44.80	+0.99
Kartoon Studios	TOON	29. nov 2024	0.67	+6.85
Karyopharm Therapeutics	KPTI	29. nov 2024	0.85	-0.87
Katapult	KPLT	29. nov 2024	7.56	+13.00
Kayne Anderson BDC	KBDC	29. nov 2024	16.75	+0.90
Kayne Anderson Energy Infrastructure Fund	KYN	29. nov 2024	13.68	+1.26
Kazia Therapeutics ADR	KZIA	29. nov 2024	5.17	-5.31
KB Financial Group ADR	KB	29. nov 2024	68.93	-2.63
KB Home	KBH	29. nov 2024	82.74	-0.14
KBR	KBR	29. nov 2024	60.83	-0.57
KBW Bank Powershares	KBWB	29. nov 2024	71.03	-0.03
KBW High Div Yield Financial Powershares	KBWD	29. nov 2024	15.51	+0.26
KBW Prem Yield Equity REIT Powershares	KBWY	29. nov 2024	20.01	-0.35
KBW Prop & Casuality Insur Powershares	KBWP	29. nov 2024	126.38	-0.02
KBW Regional Banking Powershares	KBWR	29. nov 2024	67.07	-0.47
KE Holdings	BEKE	29. nov 2024	18.85	-0.84
Kearny Financial	KRNY	29. nov 2024	7.92	-0.13
Keen Vision Acquisition	KVACU	29. nov 2024	10.90	0.00
Keen Vision Acquisition	KVAC	29. nov 2024	10.90	+0.28
Kellanova	K	29. nov 2024	81.29	+0.17
Kelly Services A	KELYA	29. nov 2024	14.65	-0.54

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.